You are here

blinatumomab

Amgen eyes a speedy approval for its leukemia contender

Fierce Biotech

Fri, 10/10/14 - 08:56 am

acute lymphoblastic leukemia

Amgen One Step Closer To Immunotherapy Market

Bidness Etc.

Tue, 09/23/14 - 07:33 am

acute lymphoblastic leukemia

Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal

Yahoo/Zacks.com

Wed, 07/9/14 - 09:26 am

Regado Biosciences

Jazz Pharmaceuticals

ASCO 2014: Doubling Down on Next-Gen Cancer Drugs

Motley Fool

Tue, 06/3/14 - 12:26 pm

biospecific antibodies

Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients

Yahoo/BusinessWire

Sun, 12/11/11 - 02:42 pm

Micromet starts mid-stage trial of leukemia treatment blinatumomab, its most advanced drug

Yahoo/AP

Tue, 11/29/11 - 08:41 am

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Seeking Alpha

Sun, 10/16/11 - 07:05 pm

acute lymphoblastic leukemia

Seattle Genetics

Great Data! Now Lets See More Than 12 Patients

Motley Fool

Sat, 06/11/11 - 10:25 am

Micromet Gains After Leukemia Medicine Helps Patients in Study

Bloomberg

Fri, 06/10/11 - 09:21 am

Major FDA Approval Could Pave the Way for These 5 Biotechs

Seeking Alpha

Thu, 03/31/11 - 11:55 am

non-Hodgkin's lymphoma

acute lymphoblastic leukemia

Micromet takes back MedImmune's blinatumomab rights

Fierce Biotech

Fri, 11/6/09 - 10:46 am

Micromet's lead drug meets midstage study goal

Yahoo/AP

Mon, 06/8/09 - 08:45 am

MedImmune returns cancer drug rights to Micromet

Yahoo/AP

Thu, 03/12/09 - 10:26 am